Literature DB >> 19336839

Phosphorylation of Nogo receptors suppresses Nogo signaling, allowing neurite regeneration.

Yoshinori Takei1.   

Abstract

The myelin-associated proteins Nogo-A, MAG, and OMgp transmit signals from oligodendrocytes into neurons through binding to Nogo receptors. Nogo signaling has critical roles in development and maintenance of the central nervous system (CNS). It can inhibit differentiation, migration, and neurite outgrowth of neurons, causing poor recovery of the adult CNS from damage. Here, I show that phosphorylation of Nogo receptors by casein kinase II (CK2) inhibits binding of the myelin-associated proteins. Brain-derived neurotrophic factor stimulates the phosphorylation, suppressing Nogo-dependent inhibition of neurite outgrowth from neuroblastoma-derived neural cells. Similarly, in rat adult neurons, extracellular CK2 treatment overcomes inhibition of neurite outgrowth by the myelin-associated proteins. These findings provide new strategies to control Nogo signaling and hence neuronal regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336839     DOI: 10.1126/scisignal.2000062

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  11 in total

Review 1.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

2.  Aptamer antagonists of myelin-derived inhibitors promote axon growth.

Authors:  Yuxuan Wang; Zin Z Khaing; Na Li; Brad Hall; Christine E Schmidt; Andrew D Ellington
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

3.  Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon.

Authors:  Vanessa Gil; Zoe Bichler; Jae K Lee; Oscar Seira; Franc Llorens; Ana Bribian; Ricardo Morales; Enric Claverol-Tinture; Eduardo Soriano; Lauro Sumoy; Binhai Zheng; Jose A Del Río
Journal:  Cereb Cortex       Date:  2009-11-05       Impact factor: 5.357

Review 4.  Targeting plasticity with vagus nerve stimulation to treat neurological disease.

Authors:  Seth A Hays; Robert L Rennaker; Michael P Kilgard
Journal:  Prog Brain Res       Date:  2013       Impact factor: 2.453

5.  Stem cells for spinal cord regeneration: Current status.

Authors:  Zain A Sobani; Syed A Quadri; S Ather Enam
Journal:  Surg Neurol Int       Date:  2010-12-25

Review 6.  Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications.

Authors:  Garif Yalak; Bjorn R Olsen
Journal:  J Transl Med       Date:  2015-04-19       Impact factor: 5.531

7.  NgR1 Expressed in P19 Embryonal Carcinoma Cells Differentiated by Retinoic Acid Can Activate STAT3.

Authors:  Su In Lee; Jieun Yun; Ji-Young Baek; Yun-Ji Jeong; Jin-Ah Kim; Jong Soon Kang; Sun Hong Park; Sang Kyum Kim; Song-Kyu Park
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

8.  Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.

Authors:  Kenji Hanamura; Halley R Washburn; Sean I Sheffler-Collins; Nan L Xia; Nathan Henderson; Dipti V Tillu; Shayne Hassler; Daniel S Spellman; Guoan Zhang; Thomas A Neubert; Theodore J Price; Matthew B Dalva
Journal:  PLoS Biol       Date:  2017-07-18       Impact factor: 8.029

9.  Ecto-domain phosphorylation promotes functional recovery from spinal cord injury.

Authors:  Kenji Suehiro; Yuka Nakamura; Shuai Xu; Youichi Uda; Takafumi Matsumura; Yoshiaki Yamaguchi; Hitoshi Okamura; Toshihide Yamashita; Yoshinori Takei
Journal:  Sci Rep       Date:  2014-05-15       Impact factor: 4.379

10.  P2Y4 Nucleotide Receptor in Neuronal Precursors Induces Glutamatergic Subtype Markers in Their Descendant Neurons.

Authors:  Youichi Uda; Shuai Xu; Takafumi Matsumura; Yoshinori Takei
Journal:  Stem Cell Reports       Date:  2016-03-10       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.